Arvinas Competitors and Similar CompaniesClear all
Arvinas's competitors and similar companies include Foghorn Therapeutics.
 Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New Haven, US HQ | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 13329% increase | Employees 1123% decrease |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) 452 m |
Financial | ||
Revenue (est.) | Revenue (est.) $262.6m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income ($80.8m) (FY, 2025) | Net income ($74.4m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 111.6m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company